Ocular Therapeutix announced the appointment of Steve Meyers as Chief Commercial Officer. Prior to joining Ocular, Meyers served as Vice President of Sales at Flexion Therapeutics in the orthopedic space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OCUL:
- Ocular Therapeutix™ Appoints Steve Meyers to Chief Commercial Officer
- Bank of America Predicts up to 160% Rally for These 2 Stocks — Here’s Why They Have Solid Upside
- Ocular Therapeutix announces first subjects screened in Phase 3 trial of AXPAXLI
- Ocular Therapeutix™ Announces First Subjects Screened in Phase 3 Pivotal Clinical Trial of AXPAXLI™ in Wet AMD
- Ocular Therapeutix announces firs subjects screened in Phase 3 trial of AXPAXLI